Discovery and Research
Kadmon employs both established and cutting-edge technologies to discover and develop therapeutics targeting the critical pathways of survival or causation in disease. Our multi-platform approach allows us to explore chemicals and biologics, recombinant therapies and gene-based therapies, as well as intracellular and extracellular effectors; all with the goal of attacking disease with maximum efficacy and specificity.
